Selected research
Market Analysis & Forecast
Global Montelukast Sodium Granules Market Analysis and Forecast 2026-2032
Market perspective
The global Montelukast Sodium Granules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Montelukast Sodium Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Montelukast Sodium Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Montelukast Sodium Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Montelukast Sodium Granules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Montelukast Sodium Granules include Teva Pharmaceutical Industries, Organon LLC, Novartis, Hengrui Medicine, Hybio Pharmaceutical, Pfizer, Mylan Pharmaceuticals, Luye Pharma Group and Dr. Reddy's Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Montelukast Sodium Granules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Montelukast Sodium Granules, also provides the sales of main regions and countries. Of the upcoming market potential for Montelukast Sodium Granules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Montelukast Sodium Granules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Montelukast Sodium Granules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Montelukast Sodium Granules sales, projected growth trends, production technology, application and end-user industry.
Montelukast Sodium Granules Segment by Company
Teva Pharmaceutical Industries
Organon LLC
Novartis
Hengrui Medicine
Hybio Pharmaceutical
Pfizer
Mylan Pharmaceuticals
Luye Pharma Group
Dr. Reddy's Laboratories
Dong-A ST
Montelukast Sodium Granules Segment by Type
5mg
10mg
Montelukast Sodium Granules Segment by Application
Hospital
Clinic
Others
Montelukast Sodium Granules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Montelukast Sodium Granules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Montelukast Sodium Granules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Montelukast Sodium Granules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Montelukast Sodium Granules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Montelukast Sodium Granules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Montelukast Sodium Granules sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 5mg
- 10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva Pharmaceutical Industries
- Organon LLC
- Novartis
- Hengrui Medicine
- Hybio Pharmaceutical
- Pfizer
- Mylan Pharmaceuticals
- Luye Pharma Group
- Dr. Reddy's Laboratories
- Dong-A ST
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Montelukast Sodium Granules Market by Type
- 1.2.1 Global Montelukast Sodium Granules Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 5mg
- 1.2.3 10mg
- 1.3 Montelukast Sodium Granules Market by Application
- 1.3.1 Global Montelukast Sodium Granules Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Montelukast Sodium Granules Market Dynamics
- 2.1 Montelukast Sodium Granules Industry Trends
- 2.2 Montelukast Sodium Granules Industry Drivers
- 2.3 Montelukast Sodium Granules Industry Opportunities and Challenges
- 2.4 Montelukast Sodium Granules Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Montelukast Sodium Granules Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Montelukast Sodium Granules Revenue by Region
- 3.2.1 Global Montelukast Sodium Granules Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Montelukast Sodium Granules Revenue by Region (2021-2026)
- 3.2.3 Global Montelukast Sodium Granules Revenue by Region (2027-2032)
- 3.2.4 Global Montelukast Sodium Granules Revenue Market Share by Region (2021-2032)
- 3.3 Global Montelukast Sodium Granules Sales Estimates and Forecasts 2021-2032
- 3.4 Global Montelukast Sodium Granules Sales by Region
- 3.4.1 Global Montelukast Sodium Granules Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Montelukast Sodium Granules Sales by Region (2021-2026)
- 3.4.3 Global Montelukast Sodium Granules Sales by Region (2027-2032)
- 3.4.4 Global Montelukast Sodium Granules Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Montelukast Sodium Granules Revenue by Manufacturers
- 4.1.1 Global Montelukast Sodium Granules Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Montelukast Sodium Granules Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Montelukast Sodium Granules Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Montelukast Sodium Granules Sales by Manufacturers
- 4.2.1 Global Montelukast Sodium Granules Sales by Manufacturers (2021-2026)
- 4.2.2 Global Montelukast Sodium Granules Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Montelukast Sodium Granules Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Montelukast Sodium Granules Sales Price by Manufacturers (2021-2026)
- 4.4 Global Montelukast Sodium Granules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Montelukast Sodium Granules Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Montelukast Sodium Granules Manufacturers, Product Type & Application
- 4.7 Global Montelukast Sodium Granules Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Montelukast Sodium Granules Market CR5 and HHI
- 4.8.2 2025 Montelukast Sodium Granules Tier 1, Tier 2, and Tier 3
5 Montelukast Sodium Granules Market by Type
- 5.1 Global Montelukast Sodium Granules Revenue by Type
- 5.1.1 Global Montelukast Sodium Granules Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Montelukast Sodium Granules Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Montelukast Sodium Granules Revenue Market Share by Type (2021-2032)
- 5.2 Global Montelukast Sodium Granules Sales by Type
- 5.2.1 Global Montelukast Sodium Granules Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Montelukast Sodium Granules Sales by Type (2021-2032) & (K G)
- 5.2.3 Global Montelukast Sodium Granules Sales Market Share by Type (2021-2032)
- 5.3 Global Montelukast Sodium Granules Price by Type
6 Montelukast Sodium Granules Market by Application
- 6.1 Global Montelukast Sodium Granules Revenue by Application
- 6.1.1 Global Montelukast Sodium Granules Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Montelukast Sodium Granules Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Montelukast Sodium Granules Revenue Market Share by Application (2021-2032)
- 6.2 Global Montelukast Sodium Granules Sales by Application
- 6.2.1 Global Montelukast Sodium Granules Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Montelukast Sodium Granules Sales by Application (2021-2032) & (K G)
- 6.2.3 Global Montelukast Sodium Granules Sales Market Share by Application (2021-2032)
- 6.3 Global Montelukast Sodium Granules Price by Application
7 Company Profiles
- 7.1 Teva Pharmaceutical Industries
- 7.1.1 Teva Pharmaceutical Industries Company Information
- 7.1.2 Teva Pharmaceutical Industries Business Overview
- 7.1.3 Teva Pharmaceutical Industries Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Teva Pharmaceutical Industries Montelukast Sodium Granules Product Portfolio
- 7.1.5 Teva Pharmaceutical Industries Recent Developments
- 7.2 Organon LLC
- 7.2.1 Organon LLC Company Information
- 7.2.2 Organon LLC Business Overview
- 7.2.3 Organon LLC Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Organon LLC Montelukast Sodium Granules Product Portfolio
- 7.2.5 Organon LLC Recent Developments
- 7.3 Novartis
- 7.3.1 Novartis Company Information
- 7.3.2 Novartis Business Overview
- 7.3.3 Novartis Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Novartis Montelukast Sodium Granules Product Portfolio
- 7.3.5 Novartis Recent Developments
- 7.4 Hengrui Medicine
- 7.4.1 Hengrui Medicine Company Information
- 7.4.2 Hengrui Medicine Business Overview
- 7.4.3 Hengrui Medicine Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Hengrui Medicine Montelukast Sodium Granules Product Portfolio
- 7.4.5 Hengrui Medicine Recent Developments
- 7.5 Hybio Pharmaceutical
- 7.5.1 Hybio Pharmaceutical Company Information
- 7.5.2 Hybio Pharmaceutical Business Overview
- 7.5.3 Hybio Pharmaceutical Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Hybio Pharmaceutical Montelukast Sodium Granules Product Portfolio
- 7.5.5 Hybio Pharmaceutical Recent Developments
- 7.6 Pfizer
- 7.6.1 Pfizer Company Information
- 7.6.2 Pfizer Business Overview
- 7.6.3 Pfizer Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Pfizer Montelukast Sodium Granules Product Portfolio
- 7.6.5 Pfizer Recent Developments
- 7.7 Mylan Pharmaceuticals
- 7.7.1 Mylan Pharmaceuticals Company Information
- 7.7.2 Mylan Pharmaceuticals Business Overview
- 7.7.3 Mylan Pharmaceuticals Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Mylan Pharmaceuticals Montelukast Sodium Granules Product Portfolio
- 7.7.5 Mylan Pharmaceuticals Recent Developments
- 7.8 Luye Pharma Group
- 7.8.1 Luye Pharma Group Company Information
- 7.8.2 Luye Pharma Group Business Overview
- 7.8.3 Luye Pharma Group Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Luye Pharma Group Montelukast Sodium Granules Product Portfolio
- 7.8.5 Luye Pharma Group Recent Developments
- 7.9 Dr. Reddy's Laboratories
- 7.9.1 Dr. Reddy's Laboratories Company Information
- 7.9.2 Dr. Reddy's Laboratories Business Overview
- 7.9.3 Dr. Reddy's Laboratories Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 Dr. Reddy's Laboratories Montelukast Sodium Granules Product Portfolio
- 7.9.5 Dr. Reddy's Laboratories Recent Developments
- 7.10 Dong-A ST
- 7.10.1 Dong-A ST Company Information
- 7.10.2 Dong-A ST Business Overview
- 7.10.3 Dong-A ST Montelukast Sodium Granules Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Dong-A ST Montelukast Sodium Granules Product Portfolio
- 7.10.5 Dong-A ST Recent Developments
8 North America
- 8.1 North America Montelukast Sodium Granules Market Size by Type
- 8.1.1 North America Montelukast Sodium Granules Revenue by Type (2021-2032)
- 8.1.2 North America Montelukast Sodium Granules Sales by Type (2021-2032)
- 8.1.3 North America Montelukast Sodium Granules Price by Type (2021-2032)
- 8.2 North America Montelukast Sodium Granules Market Size by Application
- 8.2.1 North America Montelukast Sodium Granules Revenue by Application (2021-2032)
- 8.2.2 North America Montelukast Sodium Granules Sales by Application (2021-2032)
- 8.2.3 North America Montelukast Sodium Granules Price by Application (2021-2032)
- 8.3 North America Montelukast Sodium Granules Market Size by Country
- 8.3.1 North America Montelukast Sodium Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Montelukast Sodium Granules Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Montelukast Sodium Granules Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Montelukast Sodium Granules Market Size by Type
- 9.1.1 Europe Montelukast Sodium Granules Revenue by Type (2021-2032)
- 9.1.2 Europe Montelukast Sodium Granules Sales by Type (2021-2032)
- 9.1.3 Europe Montelukast Sodium Granules Price by Type (2021-2032)
- 9.2 Europe Montelukast Sodium Granules Market Size by Application
- 9.2.1 Europe Montelukast Sodium Granules Revenue by Application (2021-2032)
- 9.2.2 Europe Montelukast Sodium Granules Sales by Application (2021-2032)
- 9.2.3 Europe Montelukast Sodium Granules Price by Application (2021-2032)
- 9.3 Europe Montelukast Sodium Granules Market Size by Country
- 9.3.1 Europe Montelukast Sodium Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Montelukast Sodium Granules Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Montelukast Sodium Granules Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Montelukast Sodium Granules Market Size by Type
- 10.1.1 China Montelukast Sodium Granules Revenue by Type (2021-2032)
- 10.1.2 China Montelukast Sodium Granules Sales by Type (2021-2032)
- 10.1.3 China Montelukast Sodium Granules Price by Type (2021-2032)
- 10.2 China Montelukast Sodium Granules Market Size by Application
- 10.2.1 China Montelukast Sodium Granules Revenue by Application (2021-2032)
- 10.2.2 China Montelukast Sodium Granules Sales by Application (2021-2032)
- 10.2.3 China Montelukast Sodium Granules Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Montelukast Sodium Granules Market Size by Type
- 11.1.1 Asia Montelukast Sodium Granules Revenue by Type (2021-2032)
- 11.1.2 Asia Montelukast Sodium Granules Sales by Type (2021-2032)
- 11.1.3 Asia Montelukast Sodium Granules Price by Type (2021-2032)
- 11.2 Asia Montelukast Sodium Granules Market Size by Application
- 11.2.1 Asia Montelukast Sodium Granules Revenue by Application (2021-2032)
- 11.2.2 Asia Montelukast Sodium Granules Sales by Application (2021-2032)
- 11.2.3 Asia Montelukast Sodium Granules Price by Application (2021-2032)
- 11.3 Asia Montelukast Sodium Granules Market Size by Country
- 11.3.1 Asia Montelukast Sodium Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Montelukast Sodium Granules Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Montelukast Sodium Granules Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Montelukast Sodium Granules Market Size by Type
- 12.1.1 SAMEA Montelukast Sodium Granules Revenue by Type (2021-2032)
- 12.1.2 SAMEA Montelukast Sodium Granules Sales by Type (2021-2032)
- 12.1.3 SAMEA Montelukast Sodium Granules Price by Type (2021-2032)
- 12.2 SAMEA Montelukast Sodium Granules Market Size by Application
- 12.2.1 SAMEA Montelukast Sodium Granules Revenue by Application (2021-2032)
- 12.2.2 SAMEA Montelukast Sodium Granules Sales by Application (2021-2032)
- 12.2.3 SAMEA Montelukast Sodium Granules Price by Application (2021-2032)
- 12.3 SAMEA Montelukast Sodium Granules Market Size by Country
- 12.3.1 SAMEA Montelukast Sodium Granules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Montelukast Sodium Granules Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Montelukast Sodium Granules Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Montelukast Sodium Granules Value Chain Analysis
- 13.1.1 Montelukast Sodium Granules Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Montelukast Sodium Granules Production Mode & Process
- 13.2 Montelukast Sodium Granules Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Montelukast Sodium Granules Distributors
- 13.2.3 Montelukast Sodium Granules Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst